Highlights from the 2020 CHDI HD Therapeutics Conference are now here! This year’s Postcard covers HTT-lowering therapeutics, including an
HDSA RESEARCH WEBINAR | APRIL 29TH AT 12PM (ET)
To learn more about the early halt of the Generation-HD1 trial, join HDSA’s webinar on Thursday, April 29th at 12pm (ET). Roche will present about the data and decision to stop dosing of tominersen in this clinical trial during a special community-focused research webinar. Many thanks to HDSA for this opportunity!